首页> 美国卫生研究院文献>OncoTargets and therapy >Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer

【2h】

Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer

机译：评估Endostar和S-1联合奥沙利铂联合治疗晚期胃癌的有效性和安全性的随机对照临床试验结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesWe aimed to evaluate the efficacy and safety of combination therapy of Endostar (recombinant human endostatin) and S-1 combined with oxaliplatin (SOX) in patients with advanced gastric cancer.

机译：目的我们旨在评估Endostar（重组人内皮抑素）和S-1联合奥沙利铂（SOX）联合治疗晚期胃癌的疗效和安全性。

著录项

期刊名称 OncoTargets and therapy
作者
Rong Xu; Nan Ma; Fang Wang; Lei Ma; Rui Chen; Ru Chen; Mijiti Kebinu; Lili Ma; Zhongcheng Han; Ayixiamu; Mahemiti Mayier; Pengcheng Su; Yiming Naman; Haliyazimu Jieensi; Haixuan Yang; Abulizi Adili; Saiding Aili; Jiang Liu;
展开▼
作者单位

展开▼
年(卷),期 2013(6),-1
年度 2013
页码 925–929
总页数 5
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
endostatin gastric cancer SOX oxaliplatin Endostar S-1;

机译：内皮抑素;胃癌;SOX;奥沙利铂;Endostar;S-1;

相似文献

外文文献
中文文献
专利

1. Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer [J] . Rong Xu, Nan Ma, Fang Wang, OncoTargets and therapy . 2013,第4期

机译：评估Endostar和S-1联合奥沙利铂联合治疗晚期胃癌的有效性和安全性的随机对照临床试验结果
2. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial [J] . Xinxin Wang, Shuo Li, Yihong Sun, BMC Cancer . 2021,第1期

机译：评估欧洲血红素蛋白的不同循环的预期，多中心，随机，受访期III研究的议定书，作为局部晚期胃癌患者的Neoadjuvant化疗：共鸣-II试验
3. A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy [J] . Masahiro Katsuda, Motoki Miyazawa, Toshiyasu Ojima, Trials . 2019,第1期

机译：一种双盲随机比较临床试验，以评估用WT1肽（TLP0-001）的树突状细胞疫苗的安全性和有效性与S-1组合在患有先进的胰腺癌难治度到标准化疗的患者
4. S-1/CDDP/Lentinan Combination Chemotherapy for Inoperable Advanced Gastric Cancer [C] . Shoichi Nagahashi, Hidekazu Suzuki, Toshifumi Hib International Gastric Cancer Congress . 2005

机译：S-1 / CDDP / Lentinan组合化疗，可管理的胃癌无法操作
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. The protocol of a prospective multicenter randomized controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial [O] . Xinxin Wang, Shuo Li, Yihong Sun, 2021

机译：评估当地晚期胃癌患者的欧洲蛋白和S-1（SOX）与S-1（SOX）相结合的不同循环的预期多中心随机的控制阶段III研究的议定书评估作为Neoadjuvant化疗：共鸣-II试验
7. Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4) [O] . N. Boku, M.-H. Ryu, K. Kato, 2019

机译：Nivolumab与S-1 / Capecitabine Plus Oxaliplatin的安全性和有效性在以前未经治疗，不可切除，晚期或复发性胃/胃食管接线癌症的患者中：随机，第二阶段试验（吸引力-4）的中期结果

Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer

摘要

著录项

相似文献

相关主题

期刊订阅